GlaxoSmithKline Pharmaceuticals Limited has received a decree from the Court of Small Causes, Bombay, related to a dispute over office premises formerly used by Burroughs Wellcome (India) Limited. The total demand is Rs. 38.06 crores. The company is evaluating the decree and plans to take appropriate actions, including potentially filing an appeal. The matter concerns a dispute dating back over 24 years.
Court Decree Received
GlaxoSmithKline Pharmaceuticals Limited has been notified of a decree issued by the Court of Small Causes, Bombay. The decree pertains to a matter involving office premises previously occupied by Burroughs Wellcome (India) Limited before its merger.
Financial Implications
The total demand specified in the decree amounts to Rs. 38.06 crores. This amount relates to Mesne Profit for the office premises used by the former Burroughs Wellcome (India) Limited. The amount includes Rs 87.09 lakhs along with simple interest at a 9% rate from June 2001, totaling Rs 37.19 crores.
Company Response
The company is currently evaluating the decree and is preparing to take suitable actions. This includes the possibility of filing an appeal within the appropriate timeframe to mitigate any potential impacts. The decree was initially issued on May 6th, 2025 and received by the company on November 2nd, 2025.
Historical Context
The dispute concerns a case that is over 24 years old. Due to the age of the case and the company’s lack of records, confirming its attribution was not immediately possible, leading to a delay in reporting.
Source: BSE
